BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2020.
World J Clin Cases. Nov 6, 2020; 8(21): 5116-5127
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5116
Table 3 Treatment characteristics of primary normal size ovarian cancer syndrome and papillary serous ovarian carcinoma, n (%)
Characteristic, patients with data availableNOCSPSOCP value
Initial surgery0.892
Complete79 (71.8)108 (71.1)
Incomplete31 (28.2)44 (28.9)
Operation method0.000
Laparotomy49 (44.5)112 (73.7)
Laparoscopy61 (55.5)40 (26.3)
Residual tumor0.136
Yes67 (60.9)106 (69.7)
No43 (39.1)46 (30.3)
Chemotherapy0.000
Platinum-based86 (77.3)142 (93.4)
Nonplatinum-based3 (2.7)0 (0.0)
Without22 (20)10 (6.6)
Chemotherapy numbers0.051
≥ 658 (65.2)74 (52.1)
< 631 (34.8)68 (47.9)


Write to the Help Desk